 | • レポートコード：MRC2-11QY04489 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、132ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は呼吸器疾患検査/診断のグローバル市場について調査・分析したレポートです。種類別（画像検査、呼吸測定、血液ガス検査、その他）市場規模、用途別（病院、医師クリニック、臨床検査室、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別呼吸器疾患検査/診断の競争状況、市場シェア ・世界の呼吸器疾患検査/診断市場：種類別市場規模 2015年-2020年（画像検査、呼吸測定、血液ガス検査、その他） ・世界の呼吸器疾患検査/診断市場：種類別市場規模予測 2021年-2026年（画像検査、呼吸測定、血液ガス検査、その他） ・世界の呼吸器疾患検査/診断市場：用途別市場規模 2015年-2020年（病院、医師クリニック、臨床検査室、その他） ・世界の呼吸器疾患検査/診断市場：用途別市場規模予測 2021年-2026年（病院、医師クリニック、臨床検査室、その他） ・北米の呼吸器疾患検査/診断市場分析：米国、カナダ ・ヨーロッパの呼吸器疾患検査/診断市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの呼吸器疾患検査/診断市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の呼吸器疾患検査/診断市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの呼吸器疾患検査/診断市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Becton Dickinson、Abbott Laboratories、Abbott、Cepheid、Fischer and Paykel、Futuremed、Hoffmann-La Roche、Instrumentation Laboratories、Medtronic、NDD Medical Technologies、Nihon Kohden、Philips Medical Systems、SDI Diagnostics、Seegene、Smiths Medical ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Respiratory measuring devices, also known as respirometers, include respirometers, pulse oximeters, carbonic acid meters, and peak flow meters.
The prevalence of respiratory diseases such as chronic obstructive pulmonary disease, asthma and other respiratory infections, as well as the increasing popularity of portable devices such as advanced respirometers and non-invasive ventilators are the leading causes of North America.
Market Analysis and Insights: Global Respiratory Disease Testing/Diagnostics Market
The global Respiratory Disease Testing/Diagnostics market size is projected to reach US$ 4622 million by 2026, from US$ 4530.3 million in 2020, at a CAGR of 1.9%% during 2021-2026.
Global Respiratory Disease Testing/Diagnostics Scope and Market Size
Respiratory Disease Testing/Diagnostics market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Respiratory Disease Testing/Diagnostics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Becton Dickinson
Abbott Laboratories
Abbott
Cepheid
Fischer and Paykel
Futuremed
Hoffmann-La Roche
Instrumentation Laboratories
Medtronic
NDD Medical Technologies
Nihon Kohden
Philips Medical Systems
SDI Diagnostics
Seegene
Smiths Medical
Market segment by Type, the product can be split into
Imaging Test
Respiratory Measurement
Blood Gas Test
Other
Market segment by Application, split into
Hospitals
Physician Clinics
Clinical Laboratories
Other
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Respiratory Disease Testing/Diagnostics Revenue
1.4 Market by Type
1.4.1 Global Respiratory Disease Testing/Diagnostics Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Imaging Test
1.4.3 Respiratory Measurement
1.4.4 Blood Gas Test
1.4.5 Other
1.5 Market by Application
1.5.1 Global Respiratory Disease Testing/Diagnostics Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Physician Clinics
1.5.4 Clinical Laboratories
1.5.5 Other
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Respiratory Disease Testing/Diagnostics Market Perspective (2015-2026)
2.2 Global Respiratory Disease Testing/Diagnostics Growth Trends by Regions
2.2.1 Respiratory Disease Testing/Diagnostics Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Respiratory Disease Testing/Diagnostics Historic Market Share by Regions (2015-2020)
2.2.3 Respiratory Disease Testing/Diagnostics Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Respiratory Disease Testing/Diagnostics Market Growth Strategy
2.3.6 Primary Interviews with Key Respiratory Disease Testing/Diagnostics Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Respiratory Disease Testing/Diagnostics Players by Market Size
3.1.1 Global Top Respiratory Disease Testing/Diagnostics Players by Revenue (2015-2020)
3.1.2 Global Respiratory Disease Testing/Diagnostics Revenue Market Share by Players (2015-2020)
3.1.3 Global Respiratory Disease Testing/Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Respiratory Disease Testing/Diagnostics Market Concentration Ratio
3.2.1 Global Respiratory Disease Testing/Diagnostics Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Respiratory Disease Testing/Diagnostics Revenue in 2019
3.3 Respiratory Disease Testing/Diagnostics Key Players Head office and Area Served
3.4 Key Players Respiratory Disease Testing/Diagnostics Product Solution and Service
3.5 Date of Enter into Respiratory Disease Testing/Diagnostics Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Respiratory Disease Testing/Diagnostics Historic Market Size by Type (2015-2020)
4.2 Global Respiratory Disease Testing/Diagnostics Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Respiratory Disease Testing/Diagnostics Market Size by Application (2015-2020)
5.2 Global Respiratory Disease Testing/Diagnostics Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Respiratory Disease Testing/Diagnostics Market Size (2015-2020)
6.2 Respiratory Disease Testing/Diagnostics Key Players in North America (2019-2020)
6.3 North America Respiratory Disease Testing/Diagnostics Market Size by Type (2015-2020)
6.4 North America Respiratory Disease Testing/Diagnostics Market Size by Application (2015-2020)
7 Europe
7.1 Europe Respiratory Disease Testing/Diagnostics Market Size (2015-2020)
7.2 Respiratory Disease Testing/Diagnostics Key Players in Europe (2019-2020)
7.3 Europe Respiratory Disease Testing/Diagnostics Market Size by Type (2015-2020)
7.4 Europe Respiratory Disease Testing/Diagnostics Market Size by Application (2015-2020)
8 China
8.1 China Respiratory Disease Testing/Diagnostics Market Size (2015-2020)
8.2 Respiratory Disease Testing/Diagnostics Key Players in China (2019-2020)
8.3 China Respiratory Disease Testing/Diagnostics Market Size by Type (2015-2020)
8.4 China Respiratory Disease Testing/Diagnostics Market Size by Application (2015-2020)
9 Japan
9.1 Japan Respiratory Disease Testing/Diagnostics Market Size (2015-2020)
9.2 Respiratory Disease Testing/Diagnostics Key Players in Japan (2019-2020)
9.3 Japan Respiratory Disease Testing/Diagnostics Market Size by Type (2015-2020)
9.4 Japan Respiratory Disease Testing/Diagnostics Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Respiratory Disease Testing/Diagnostics Market Size (2015-2020)
10.2 Respiratory Disease Testing/Diagnostics Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Respiratory Disease Testing/Diagnostics Market Size by Type (2015-2020)
10.4 Southeast Asia Respiratory Disease Testing/Diagnostics Market Size by Application (2015-2020)
11 India
11.1 India Respiratory Disease Testing/Diagnostics Market Size (2015-2020)
11.2 Respiratory Disease Testing/Diagnostics Key Players in India (2019-2020)
11.3 India Respiratory Disease Testing/Diagnostics Market Size by Type (2015-2020)
11.4 India Respiratory Disease Testing/Diagnostics Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Respiratory Disease Testing/Diagnostics Market Size (2015-2020)
12.2 Respiratory Disease Testing/Diagnostics Key Players in Central & South America (2019-2020)
12.3 Central & South America Respiratory Disease Testing/Diagnostics Market Size by Type (2015-2020)
12.4 Central & South America Respiratory Disease Testing/Diagnostics Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Becton Dickinson
13.1.1 Becton Dickinson Company Details
13.1.2 Becton Dickinson Business Overview
13.1.3 Becton Dickinson Respiratory Disease Testing/Diagnostics Introduction
13.1.4 Becton Dickinson Revenue in Respiratory Disease Testing/Diagnostics Business (2015-2020))
13.1.5 Becton Dickinson Recent Development
13.2 Abbott Laboratories
13.2.1 Abbott Laboratories Company Details
13.2.2 Abbott Laboratories Business Overview
13.2.3 Abbott Laboratories Respiratory Disease Testing/Diagnostics Introduction
13.2.4 Abbott Laboratories Revenue in Respiratory Disease Testing/Diagnostics Business (2015-2020)
13.2.5 Abbott Laboratories Recent Development
13.3 Abbott
13.3.1 Abbott Company Details
13.3.2 Abbott Business Overview
13.3.3 Abbott Respiratory Disease Testing/Diagnostics Introduction
13.3.4 Abbott Revenue in Respiratory Disease Testing/Diagnostics Business (2015-2020)
13.3.5 Abbott Recent Development
13.4 Cepheid
13.4.1 Cepheid Company Details
13.4.2 Cepheid Business Overview
13.4.3 Cepheid Respiratory Disease Testing/Diagnostics Introduction
13.4.4 Cepheid Revenue in Respiratory Disease Testing/Diagnostics Business (2015-2020)
13.4.5 Cepheid Recent Development
13.5 Fischer and Paykel
13.5.1 Fischer and Paykel Company Details
13.5.2 Fischer and Paykel Business Overview
13.5.3 Fischer and Paykel Respiratory Disease Testing/Diagnostics Introduction
13.5.4 Fischer and Paykel Revenue in Respiratory Disease Testing/Diagnostics Business (2015-2020)
13.5.5 Fischer and Paykel Recent Development
13.6 Futuremed
13.6.1 Futuremed Company Details
13.6.2 Futuremed Business Overview
13.6.3 Futuremed Respiratory Disease Testing/Diagnostics Introduction
13.6.4 Futuremed Revenue in Respiratory Disease Testing/Diagnostics Business (2015-2020)
13.6.5 Futuremed Recent Development
13.7 Hoffmann-La Roche
13.7.1 Hoffmann-La Roche Company Details
13.7.2 Hoffmann-La Roche Business Overview
13.7.3 Hoffmann-La Roche Respiratory Disease Testing/Diagnostics Introduction
13.7.4 Hoffmann-La Roche Revenue in Respiratory Disease Testing/Diagnostics Business (2015-2020)
13.7.5 Hoffmann-La Roche Recent Development
13.8 Instrumentation Laboratories
13.8.1 Instrumentation Laboratories Company Details
13.8.2 Instrumentation Laboratories Business Overview
13.8.3 Instrumentation Laboratories Respiratory Disease Testing/Diagnostics Introduction
13.8.4 Instrumentation Laboratories Revenue in Respiratory Disease Testing/Diagnostics Business (2015-2020)
13.8.5 Instrumentation Laboratories Recent Development
13.9 Medtronic
13.9.1 Medtronic Company Details
13.9.2 Medtronic Business Overview
13.9.3 Medtronic Respiratory Disease Testing/Diagnostics Introduction
13.9.4 Medtronic Revenue in Respiratory Disease Testing/Diagnostics Business (2015-2020)
13.9.5 Medtronic Recent Development
13.10 NDD Medical Technologies
13.10.1 NDD Medical Technologies Company Details
13.10.2 NDD Medical Technologies Business Overview
13.10.3 NDD Medical Technologies Respiratory Disease Testing/Diagnostics Introduction
13.10.4 NDD Medical Technologies Revenue in Respiratory Disease Testing/Diagnostics Business (2015-2020)
13.10.5 NDD Medical Technologies Recent Development
13.11 Nihon Kohden
10.11.1 Nihon Kohden Company Details
10.11.2 Nihon Kohden Business Overview
10.11.3 Nihon Kohden Respiratory Disease Testing/Diagnostics Introduction
10.11.4 Nihon Kohden Revenue in Respiratory Disease Testing/Diagnostics Business (2015-2020)
10.11.5 Nihon Kohden Recent Development
13.12 Philips Medical Systems
10.12.1 Philips Medical Systems Company Details
10.12.2 Philips Medical Systems Business Overview
10.12.3 Philips Medical Systems Respiratory Disease Testing/Diagnostics Introduction
10.12.4 Philips Medical Systems Revenue in Respiratory Disease Testing/Diagnostics Business (2015-2020)
10.12.5 Philips Medical Systems Recent Development
13.13 SDI Diagnostics
10.13.1 SDI Diagnostics Company Details
10.13.2 SDI Diagnostics Business Overview
10.13.3 SDI Diagnostics Respiratory Disease Testing/Diagnostics Introduction
10.13.4 SDI Diagnostics Revenue in Respiratory Disease Testing/Diagnostics Business (2015-2020)
10.13.5 SDI Diagnostics Recent Development
13.14 Seegene
10.14.1 Seegene Company Details
10.14.2 Seegene Business Overview
10.14.3 Seegene Respiratory Disease Testing/Diagnostics Introduction
10.14.4 Seegene Revenue in Respiratory Disease Testing/Diagnostics Business (2015-2020)
10.14.5 Seegene Recent Development
13.15 Smiths Medical
10.15.1 Smiths Medical Company Details
10.15.2 Smiths Medical Business Overview
10.15.3 Smiths Medical Respiratory Disease Testing/Diagnostics Introduction
10.15.4 Smiths Medical Revenue in Respiratory Disease Testing/Diagnostics Business (2015-2020)
10.15.5 Smiths Medical Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Respiratory Disease Testing/Diagnostics Key Market Segments
Table 2. Key Players Covered: Ranking by Respiratory Disease Testing/Diagnostics Revenue
Table 3. Ranking of Global Top Respiratory Disease Testing/Diagnostics Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Respiratory Disease Testing/Diagnostics Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Imaging Test
Table 6. Key Players of Respiratory Measurement
Table 7. Key Players of Blood Gas Test
Table 8. Key Players of Other
Table 9. Global Respiratory Disease Testing/Diagnostics Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 10. Global Respiratory Disease Testing/Diagnostics Market Size by Regions (US$ Million): 2020 VS 2026
Table 11. Global Respiratory Disease Testing/Diagnostics Market Size by Regions (2015-2020) (US$ Million)
Table 12. Global Respiratory Disease Testing/Diagnostics Market Share by Regions (2015-2020)
Table 13. Global Respiratory Disease Testing/Diagnostics Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 14. Global Respiratory Disease Testing/Diagnostics Market Share by Regions (2021-2026)
Table 15. Market Top Trends
Table 16. Key Drivers: Impact Analysis
Table 17. Key Challenges
Table 18. Respiratory Disease Testing/Diagnostics Market Growth Strategy
Table 19. Main Points Interviewed from Key Respiratory Disease Testing/Diagnostics Players
Table 20. Global Respiratory Disease Testing/Diagnostics Revenue by Players (2015-2020) (Million US$)
Table 21. Global Respiratory Disease Testing/Diagnostics Market Share by Players (2015-2020)
Table 22. Global Top Respiratory Disease Testing/Diagnostics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Respiratory Disease Testing/Diagnostics as of 2019)
Table 23. Global Respiratory Disease Testing/Diagnostics by Players Market Concentration Ratio (CR5 and HHI)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players Respiratory Disease Testing/Diagnostics Product Solution and Service
Table 26. Date of Enter into Respiratory Disease Testing/Diagnostics Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Respiratory Disease Testing/Diagnostics Market Size by Type (2015-2020) (Million US$)
Table 29. Global Respiratory Disease Testing/Diagnostics Market Size Share by Type (2015-2020)
Table 30. Global Respiratory Disease Testing/Diagnostics Revenue Market Share by Type (2021-2026)
Table 31. Global Respiratory Disease Testing/Diagnostics Market Size Share by Application (2015-2020)
Table 32. Global Respiratory Disease Testing/Diagnostics Market Size by Application (2015-2020) (Million US$)
Table 33. Global Respiratory Disease Testing/Diagnostics Market Size Share by Application (2021-2026)
Table 34. North America Key Players Respiratory Disease Testing/Diagnostics Revenue (2019-2020) (Million US$)
Table 35. North America Key Players Respiratory Disease Testing/Diagnostics Market Share (2019-2020)
Table 36. North America Respiratory Disease Testing/Diagnostics Market Size by Type (2015-2020) (Million US$)
Table 37. North America Respiratory Disease Testing/Diagnostics Market Share by Type (2015-2020)
Table 38. North America Respiratory Disease Testing/Diagnostics Market Size by Application (2015-2020) (Million US$)
Table 39. North America Respiratory Disease Testing/Diagnostics Market Share by Application (2015-2020)
Table 40. Europe Key Players Respiratory Disease Testing/Diagnostics Revenue (2019-2020) (Million US$)
Table 41. Europe Key Players Respiratory Disease Testing/Diagnostics Market Share (2019-2020)
Table 42. Europe Respiratory Disease Testing/Diagnostics Market Size by Type (2015-2020) (Million US$)
Table 43. Europe Respiratory Disease Testing/Diagnostics Market Share by Type (2015-2020)
Table 44. Europe Respiratory Disease Testing/Diagnostics Market Size by Application (2015-2020) (Million US$)
Table 45. Europe Respiratory Disease Testing/Diagnostics Market Share by Application (2015-2020)
Table 46. China Key Players Respiratory Disease Testing/Diagnostics Revenue (2019-2020) (Million US$)
Table 47. China Key Players Respiratory Disease Testing/Diagnostics Market Share (2019-2020)
Table 48. China Respiratory Disease Testing/Diagnostics Market Size by Type (2015-2020) (Million US$)
Table 49. China Respiratory Disease Testing/Diagnostics Market Share by Type (2015-2020)
Table 50. China Respiratory Disease Testing/Diagnostics Market Size by Application (2015-2020) (Million US$)
Table 51. China Respiratory Disease Testing/Diagnostics Market Share by Application (2015-2020)
Table 52. Japan Key Players Respiratory Disease Testing/Diagnostics Revenue (2019-2020) (Million US$)
Table 53. Japan Key Players Respiratory Disease Testing/Diagnostics Market Share (2019-2020)
Table 54. Japan Respiratory Disease Testing/Diagnostics Market Size by Type (2015-2020) (Million US$)
Table 55. Japan Respiratory Disease Testing/Diagnostics Market Share by Type (2015-2020)
Table 56. Japan Respiratory Disease Testing/Diagnostics Market Size by Application (2015-2020) (Million US$)
Table 57. Japan Respiratory Disease Testing/Diagnostics Market Share by Application (2015-2020)
Table 58. Southeast Asia Key Players Respiratory Disease Testing/Diagnostics Revenue (2019-2020) (Million US$)
Table 59. Southeast Asia Key Players Respiratory Disease Testing/Diagnostics Market Share (2019-2020)
Table 60. Southeast Asia Respiratory Disease Testing/Diagnostics Market Size by Type (2015-2020) (Million US$)
Table 61. Southeast Asia Respiratory Disease Testing/Diagnostics Market Share by Type (2015-2020)
Table 62. Southeast Asia Respiratory Disease Testing/Diagnostics Market Size by Application (2015-2020) (Million US$)
Table 63. Southeast Asia Respiratory Disease Testing/Diagnostics Market Share by Application (2015-2020)
Table 64. India Key Players Respiratory Disease Testing/Diagnostics Revenue (2019-2020) (Million US$)
Table 65. India Key Players Respiratory Disease Testing/Diagnostics Market Share (2019-2020)
Table 66. India Respiratory Disease Testing/Diagnostics Market Size by Type (2015-2020) (Million US$)
Table 67. India Respiratory Disease Testing/Diagnostics Market Share by Type (2015-2020)
Table 68. India Respiratory Disease Testing/Diagnostics Market Size by Application (2015-2020) (Million US$)
Table 69. India Respiratory Disease Testing/Diagnostics Market Share by Application (2015-2020)
Table 70. Central & South America Key Players Respiratory Disease Testing/Diagnostics Revenue (2019-2020) (Million US$)
Table 71. Central & South America Key Players Respiratory Disease Testing/Diagnostics Market Share (2019-2020)
Table 72. Central & South America Respiratory Disease Testing/Diagnostics Market Size by Type (2015-2020) (Million US$)
Table 73. Central & South America Respiratory Disease Testing/Diagnostics Market Share by Type (2015-2020)
Table 74. Central & South America Respiratory Disease Testing/Diagnostics Market Size by Application (2015-2020) (Million US$)
Table 75. Central & South America Respiratory Disease Testing/Diagnostics Market Share by Application (2015-2020)
Table 76. Becton Dickinson Company Details
Table 77. Becton Dickinson Business Overview
Table 78. Becton Dickinson Product
Table 79. Becton Dickinson Revenue in Respiratory Disease Testing/Diagnostics Business (2015-2020) (Million US$)
Table 80. Becton Dickinson Recent Development
Table 81. Abbott Laboratories Company Details
Table 82. Abbott Laboratories Business Overview
Table 83. Abbott Laboratories Product
Table 84. Abbott Laboratories Revenue in Respiratory Disease Testing/Diagnostics Business (2015-2020) (Million US$)
Table 85. Abbott Laboratories Recent Development
Table 86. Abbott Company Details
Table 87. Abbott Business Overview
Table 88. Abbott Product
Table 89. Abbott Revenue in Respiratory Disease Testing/Diagnostics Business (2015-2020) (Million US$)
Table 90. Abbott Recent Development
Table 91. Cepheid Company Details
Table 92. Cepheid Business Overview
Table 93. Cepheid Product
Table 94. Cepheid Revenue in Respiratory Disease Testing/Diagnostics Business (2015-2020) (Million US$)
Table 95. Cepheid Recent Development
Table 96. Fischer and Paykel Company Details
Table 97. Fischer and Paykel Business Overview
Table 98. Fischer and Paykel Product
Table 99. Fischer and Paykel Revenue in Respiratory Disease Testing/Diagnostics Business (2015-2020) (Million US$)
Table 100. Fischer and Paykel Recent Development
Table 101. Futuremed Company Details
Table 102. Futuremed Business Overview
Table 103. Futuremed Product
Table 104. Futuremed Revenue in Respiratory Disease Testing/Diagnostics Business (2015-2020) (Million US$)
Table 105. Futuremed Recent Development
Table 106. Hoffmann-La Roche Company Details
Table 107. Hoffmann-La Roche Business Overview
Table 108. Hoffmann-La Roche Product
Table 109. Hoffmann-La Roche Revenue in Respiratory Disease Testing/Diagnostics Business (2015-2020) (Million US$)
Table 110. Hoffmann-La Roche Recent Development
Table 111. Instrumentation Laboratories Business Overview
Table 112. Instrumentation Laboratories Product
Table 113. Instrumentation Laboratories Company Details
Table 114. Instrumentation Laboratories Revenue in Respiratory Disease Testing/Diagnostics Business (2015-2020) (Million US$)
Table 115. Instrumentation Laboratories Recent Development
Table 116. Medtronic Company Details
Table 117. Medtronic Business Overview
Table 118. Medtronic Product
Table 119. Medtronic Revenue in Respiratory Disease Testing/Diagnostics Business (2015-2020) (Million US$)
Table 120. Medtronic Recent Development
Table 121. NDD Medical Technologies Company Details
Table 122. NDD Medical Technologies Business Overview
Table 123. NDD Medical Technologies Product
Table 124. NDD Medical Technologies Revenue in Respiratory Disease Testing/Diagnostics Business (2015-2020) (Million US$)
Table 125. NDD Medical Technologies Recent Development
Table 126. Nihon Kohden Company Details
Table 127. Nihon Kohden Business Overview
Table 128. Nihon Kohden Product
Table 129. Nihon Kohden Revenue in Respiratory Disease Testing/Diagnostics Business (2015-2020) (Million US$)
Table 130. Nihon Kohden Recent Development
Table 131. Philips Medical Systems Company Details
Table 132. Philips Medical Systems Business Overview
Table 133. Philips Medical Systems Product
Table 134. Philips Medical Systems Revenue in Respiratory Disease Testing/Diagnostics Business (2015-2020) (Million US$)
Table 135. Philips Medical Systems Recent Development
Table 136. SDI Diagnostics Company Details
Table 137. SDI Diagnostics Business Overview
Table 138. SDI Diagnostics Product
Table 139. SDI Diagnostics Revenue in Respiratory Disease Testing/Diagnostics Business (2015-2020) (Million US$)
Table 140. SDI Diagnostics Recent Development
Table 141. Seegene Company Details
Table 142. Seegene Business Overview
Table 143. Seegene Product
Table 144. Seegene Revenue in Respiratory Disease Testing/Diagnostics Business (2015-2020) (Million US$)
Table 145. Seegene Recent Development
Table 146. Smiths Medical Company Details
Table 147. Smiths Medical Business Overview
Table 148. Smiths Medical Product
Table 149. Smiths Medical Revenue in Respiratory Disease Testing/Diagnostics Business (2015-2020) (Million US$)
Table 150. Smiths Medical Recent Development
Table 151. Research Programs/Design for This Report
Table 152. Key Data Information from Secondary Sources
Table 153. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Respiratory Disease Testing/Diagnostics Market Share by Type: 2020 VS 2026
Figure 2. Imaging Test Features
Figure 3. Respiratory Measurement Features
Figure 4. Blood Gas Test Features
Figure 5. Other Features
Figure 6. Global Respiratory Disease Testing/Diagnostics Market Share by Application: 2020 VS 2026
Figure 7. Hospitals Case Studies
Figure 8. Physician Clinics Case Studies
Figure 9. Clinical Laboratories Case Studies
Figure 10. Other Case Studies
Figure 11. Respiratory Disease Testing/Diagnostics Report Years Considered
Figure 12. Global Respiratory Disease Testing/Diagnostics Market Size YoY Growth 2015-2026 (US$ Million)
Figure 13. Global Respiratory Disease Testing/Diagnostics Market Share by Regions: 2020 VS 2026
Figure 14. Global Respiratory Disease Testing/Diagnostics Market Share by Regions (2021-2026)
Figure 15. Porter's Five Forces Analysis
Figure 16. Global Respiratory Disease Testing/Diagnostics Market Share by Players in 2019
Figure 17. Global Top Respiratory Disease Testing/Diagnostics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Respiratory Disease Testing/Diagnostics as of 2019
Figure 18. The Top 10 and 5 Players Market Share by Respiratory Disease Testing/Diagnostics Revenue in 2019
Figure 19. North America Respiratory Disease Testing/Diagnostics Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Europe Respiratory Disease Testing/Diagnostics Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. China Respiratory Disease Testing/Diagnostics Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Japan Respiratory Disease Testing/Diagnostics Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Southeast Asia Respiratory Disease Testing/Diagnostics Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. India Respiratory Disease Testing/Diagnostics Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Central & South America Respiratory Disease Testing/Diagnostics Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Bottom-up and Top-down Approaches for This Report
Figure 27. Data Triangulation
Figure 28. Key Executives Interviewed
感染症診断検査の世界市場（～2026年） Market Analysis and Insights: Global Infectious Disease Diagnostic Testing Market The global Infectious Disease Diagnostic Testing market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Infectious Disease Diagnostic Testing S…- 感染症検査の世界市場（～2026年） In hospitals, infectious disease specialists help ensure the timely diagnosis and treatment of acute infections by recommending the appropriate diagnostic tests to identify the source of the infection and by recommending the appropriate antibiotic to treat the infection. Biochemical tests used in th…
- 感染症検査における分子診断の世界市場（～2026年） Molecular diagnostics is a technique used to detect the presence of and identify genetic materials and proteins associated with specific health conditions and diseases, and infectious agents in body fluids such as blood, urine, or sputum. Molecular diagnostics for infectious disease testing is used …
- 牛呼吸器疾患治療の世界市場（～2026年） Bovine respiratory disease (BRD) is a multifactorial and complex disorder caused due to combination of more than one microbial pathogens, impaired host immunity, inadequate housing conditions, and environmental factors. The major factor leading to bovine respiratory diseases are host factors, enviro…
- 腸疾患検査の世界市場（～2026年） Enteric diseases are gastrointestinal infections caused by microbes such as bacteria, viruses, and parasites when they enter the body through the mouth or intestinal systems. The growth is further attributed to rising healthcare expenditure, supportive government initiatives, and augmenting disease …